Back to Search
Start Over
Anosognosia predicts default mode network hypometabolism and clinical progression to dementia
- Source :
- Neurology
- Publication Year :
- 2018
- Publisher :
- Lippincott Williams & Wilkins, 2018.
-
Abstract
- ObjectiveTo identify the pathophysiologic mechanisms and clinical significance of anosognosia for cognitive decline in mild cognitive impairment.MethodsWe stratified 468 patients with amnestic mild cognitive impairment into intact and impaired awareness groups, determined by the discrepancy between the patient and the informant score on the Everyday Cognition questionnaire. Voxel-based linear regression models evaluated the associations between self-awareness status and baseline β-amyloid load, measured by [18F]florbetapir, and the relationships between awareness status and regional brain glucose metabolism measured by [18F]fluorodeoxyglucose at baseline and at 24-month follow-up. Multivariate logistic regression tested the association of awareness status with conversion from amnestic mild cognitive impairment to dementia.ResultsWe found that participants with impaired awareness had lower [18F]fluorodeoxyglucose uptake and increased [18F]florbetapir uptake in the posterior cingulate cortex at baseline. In addition, impaired awareness in mild cognitive impairment predicted [18F]fluorodeoxyglucose hypometabolism in the posterior cingulate cortex, left basal forebrain, bilateral medial temporal lobes, and right lateral temporal lobe over 24 months. Furthermore, participants with impaired awareness had a nearly 3-fold increase in likelihood of conversion to dementia within a 2-year time frame.ConclusionsOur results suggest that anosognosia is linked to Alzheimer disease pathophysiology in vulnerable structures, and predicts subsequent hypometabolism in the default mode network, accompanied by an increased risk of progression to dementia. This highlights the importance of assessing awareness of cognitive decline in the clinical evaluation and management of individuals with amnestic mild cognitive impairment.
- Subjects :
- Male
medicine.medical_specialty
Amyloid
Apolipoprotein E4
Audiology
050105 experimental psychology
Article
Temporal lobe
03 medical and health sciences
0302 clinical medicine
Fluorodeoxyglucose F18
Medicine
Dementia
Humans
0501 psychology and cognitive sciences
Cognitive Dysfunction
Cognitive decline
Default mode network
Aged
Aniline Compounds
business.industry
Anosognosia
05 social sciences
Brain
Cognition
medicine.disease
Prognosis
Posterior cingulate
Agnosia
Disease Progression
Ethylene Glycols
Female
Neurology (clinical)
Human medicine
Alzheimer's disease
Radiopharmaceuticals
business
030217 neurology & neurosurgery
Biomarkers
Follow-Up Studies
Subjects
Details
- Language :
- English
- ISSN :
- 1526632X and 00283878
- Volume :
- 90
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- Neurology
- Accession number :
- edsair.doi.dedup.....bcfb85350b4450766a5d800e060892c1